Table 6.
Stepwise multiple linear regression analysis of SF-36 domains in gout patients
| β | SE | t | P | B (95% CI) | F | Adj R2 | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| PCS | 15.779 | 0.247 | ||||||
| Depression (PHQ-9 ≥ 10 score) | −16.649 | 3.693 | −4.508 | <0.001 | −23.928 | −9.370 | ||
| Total pain (VAS) | −1.551 | .372 | −4.165 | <0.001 | −2.285 | −0.817 | ||
| Cardiovascular disease | −12.562 | 4.342 | −2.894 | 0.004 | −21.119 | −4.006 | ||
| Number of flares/last year | −0.129 | 0.058 | −2.226 | 0.027 | −0.244 | −0.015 | ||
| Colchicine | −5.772 | 2.666 | −2.165 | 0.031 | −11.026 | −0.518 | ||
| MCS | 14.686 | 0.267 | ||||||
| Depression (PHQ-9 ≥ 10 score) | −14.268 | 3.967 | −3.596 | <0.001 | −22.088 | −6.449 | ||
| Presence of tender joints, yes | −8.333 | 3.388 | −2.460 | 0.015 | −15.010 | −1.657 | ||
| Corticosteroids | −7.758 | 2.581 | −3.006 | 0.003 | −12.844 | −2.671 | ||
| Total pain (VAS) | −0.848 | 0.353 | −2.404 | 0.017 | −1.544 | −0.153 | ||
| Anxiety (GAD-7 ≥ 10 score) | −13.452 | 6.102 | −2.204 | 0.029 | −25.477 | −1.426 | ||
VAS: visual analog scale; PHQ-9: patient health questionnaire; GAD-7: generalized anxiety disorder; SF-36: the Short Form 36 Health Survey; PCS: physical components summary; MCS: mental components summary
p values were obtained with stepwise multiple linear regression analysisanalysis
P numbers of entries with significance are shown in italics